N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine
-
![N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/31707f44ac80478d94ab99de5ecbef6f.png "N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine")
N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine
structure -
-
CAS No:
501081-38-5
-
Formula:
C28H38N6
-
Chemical Name:
N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine
-
Synonyms:
Quino[8,7-h]quinoline-1,7-diamine,N1,N7-bis[3-(dimethylamino)propyl]-3,9-dimethyl-;Quino[8,7-h]quinoline-1,7-diamine,N,N′-bis[3-(dimethylamino)propyl]-3,8-dimethyl-;N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine;NSC 306365
-
CAS No:
Description
FGI-106 is a broad-spectrum antiviral drug developed as a potential treatment for enveloped RNA viruses, in particular viral hemorrhagic fevers from the bunyavirus, flavivirus and filovirus families. It acts as an inhibitor which blocks viral entry into host cells. In animal tests FGI-106 shows both prophylactic and curative action against a range of deadly viruses for which few existing treatments are available, including the bunyaviruses Hantavirus, Rift Valley fever virus and Crimean-Congo hemorrhagic fever virus, the flavivirus Dengue virus, and the filoviruses Ebola virus and Marburg virus.
N1,N7-Bis[3-(dimethylamino)propyl]-3,9-dimethylquino[8,7-h]quinoline-1,7-diamine Basic Attributes
458.6 g/mol
458.64
BRT994456W
Computed Properties
Molecular Weight:458.6
XLogP3:5.3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:10
Exact Mass:458.31579524
Monoisotopic Mass:458.31579524
Topological Polar Surface Area:56.3
Heavy Atom Count:34
Complexity:560
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation